Clinical Trial Update: A Study Assessing the Efficacy and Safety of Lodotra® Compared to Prednisone IR in Subjects Suffering From PMR [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Lodotra to prednisone IR in polymyalgia rheumatica was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Lodotra (prednisone)
• Prednisone IR (prednisone)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Polymyalgia Rheumatica | Phase 3 | Status: TERMINATED